GL1X · GenesisL1 explorer

Research workbench

Group deposition SARS-CoV-2 main protease in complex with inhibitors from the COVID Moonshot -- Crystal Structure of SARS-CoV-2 main protease in complex with MAT-POS-f9802937-7 (Mpro-P0141)

Analyse Group deposition SARS-CoV-2 main protease in complex with inhibitors from the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7GIW
Type
protein
Length
605 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.45
Source
Severe acute respiratory syndrome coronavirus 2
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
QJF
Pockets
7 · best druggability 0.77

Structure

x-ray diffraction · resolution 2.45 · 2 distinct chains · 25% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30025% helix, 30% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein30526% helix, 29% strandP0DTD1

Ligands and binding sites

  • QJF · (4R)-6-chloro-N-(6-methoxyisoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide · ligand · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110650.770.7989DMS
2550.720.9920DMS
34870.630.7666DMS
41880.500.7630empty
51860.460.7526empty

Interfaces

1 interface between chains.

  • A–B · 1454 Ų buried · 42 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.